Guanylyl cyclase C as a biomarker for immunotherapies for the treatment of gastrointestinal malignancies.


Journal

Biomarkers in medicine
ISSN: 1752-0371
Titre abrégé: Biomark Med
Pays: England
ID NLM: 101312535

Informations de publication

Date de publication:
02 2021
Historique:
pubmed: 21 1 2021
medline: 15 12 2021
entrez: 20 1 2021
Statut: ppublish

Résumé

Gastrointestinal cancers encompass a diverse class of tumors arising in the GI tract, including esophagus, stomach, pancreas and colorectum. Collectively, gastrointestinal cancers compose a high fraction of all cancer deaths, highlighting an unmet need for novel and effective therapies. In this context, the transmembrane receptor guanylyl cyclase C (GUCY2C) has emerged as an attractive target for the prevention, detection and treatment of many gastrointestinal tumors. GUCY2C is an intestinally-restricted protein implicated in tumorigenesis that is universally expressed by primary and metastatic colorectal tumors as well as ectopically expressed by esophageal, gastric and pancreatic cancers. This review summarizes the current state of GUCY2C-targeted modalities in the management of gastrointestinal malignancies, with special focus on colorectal cancer, the most incident gastrointestinal malignancy.

Identifiants

pubmed: 33470843
doi: 10.2217/bmm-2020-0359
pmc: PMC8293028
doi:

Substances chimiques

Biomarkers 0
GUCY2C protein, human EC 4.6.1.2
Receptors, Enterotoxin EC 4.6.1.2

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

201-217

Subventions

Organisme : NCI NIH HHS
ID : F31 CA225123
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA204481
Pays : United States
Organisme : NCI NIH HHS
ID : F30 CA232469
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA206026
Pays : United States
Organisme : NIDDK NIH HHS
ID : F30 DK127639
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA056036
Pays : United States

Références

Gastroenterology. 1994 Dec;107(6):1653-61
pubmed: 7958675
PLoS One. 2015 Dec 29;10(12):e0146042
pubmed: 26713849
N Engl J Med. 2018 Feb 1;378(5):439-448
pubmed: 29385370
Gut. 2016 Aug;65(8):1306-13
pubmed: 25994218
JAMA. 2009 Feb 18;301(7):745-52
pubmed: 19224751
Gastroenterology. 2019 Sep;157(3):672-681.e4
pubmed: 31103628
Oncogene. 2015 Mar 19;34(12):1499-509
pubmed: 24704829
Biochem Biophys Res Commun. 2000 Jun 24;273(1):225-30
pubmed: 10873591
Diagn Mol Pathol. 2010 Mar;19(1):20-7
pubmed: 20186008
J Biol Chem. 2018 May 25;293(21):8173-8181
pubmed: 29653944
Lancet. 2019 Aug 31;394(10200):793-804
pubmed: 31478503
Dig Dis Sci. 1987 Sep;32(9):1017-26
pubmed: 3304888
Science. 1997 May 23;276(5316):1268-72
pubmed: 9157888
Ann Oncol. 2009 May;20 Suppl 4:49-50
pubmed: 19454461
Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14827-32
pubmed: 8962140
Biosci Rep. 1999 Jun;19(3):179-88
pubmed: 10513895
Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3352-7
pubmed: 10737795
Hum Pathol. 2005 Feb;36(2):170-9
pubmed: 15754294
Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1709-14
pubmed: 9465081
Pharmacol Rev. 2000 Sep;52(3):375-414
pubmed: 10977868
PLoS Med. 2013;10(5):e1001453
pubmed: 23700391
J Biol Chem. 2002 Jun 21;277(25):22934-41
pubmed: 11950846
Br J Pharmacol. 1994 May;112(1):31-6
pubmed: 7518307
Nutr Rev. 2015 Sep;73 Suppl 2:57-72
pubmed: 26290292
FEBS Lett. 1996 Apr 8;384(1):75-7
pubmed: 8797807
Dis Colon Rectum. 1996 Feb;39(2):171-81
pubmed: 8620784
Mol Ther. 2009 Aug;17(8):1453-64
pubmed: 19384291
Am J Gastroenterol. 2018 Jan;113(1):105-114
pubmed: 29091082
Gastroenterology. 2000 Jul;119(1):89-96
pubmed: 10889158
J Mol Evol. 2009 Jun;68(6):587-602
pubmed: 19495554
Biochem J. 2004 May 1;379(Pt 3):653-63
pubmed: 14748740
Physiol Rev. 2016 Apr;96(2):751-804
pubmed: 27030537
Brain Struct Funct. 2019 Nov;224(8):2983-2999
pubmed: 31485718
Oncogene. 2015 Feb 19;34(8):939-50
pubmed: 24632617
Gastroenterology. 2017 Oct;153(4):910-923
pubmed: 28807841
Cancer Res. 2009 Apr 15;69(8):3537-44
pubmed: 19351847
Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1466-71
pubmed: 9465038
Sci Rep. 2016 Jul 15;6:29765
pubmed: 27416752
J Clin Pathol. 2010 Jun;63(6):530-7
pubmed: 20498026
J Clin Invest. 1995 Aug;96(2):822-30
pubmed: 7543493
Gastroenterology. 2000 Jan;118(1):108-14
pubmed: 10611159
Am J Gastroenterol. 2018 Mar;113(3):329-338
pubmed: 29380823
Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2695-9
pubmed: 12594332
Mol Cell Biochem. 1996 Dec 20;165(2):111-20
pubmed: 8979259
Toxins (Basel). 2017 Sep 12;9(9):
pubmed: 28895923
J Virol. 2000 Sep;74(18):8762-6
pubmed: 10954580
J Biol Chem. 2013 Feb 8;288(6):3907-17
pubmed: 23269669
J Immunother Cancer. 2019 Apr 23;7(1):104
pubmed: 31010434
Mol Cell Biochem. 2010 Jan;334(1-2):67-80
pubmed: 19960363
Oncoimmunology. 2016 Sep 2;5(10):e1227897
pubmed: 27853651
Oncotarget. 2014 Oct 15;5(19):9460-71
pubmed: 25294806
Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2328-37
pubmed: 25304930
Arch Pathol Lab Med. 2016 May;140(5):406-12
pubmed: 27128298
Transplant Proc. 1989 Feb;21(1 Pt 1):127-30
pubmed: 2784887
Front Immunol. 2019 Oct 11;10:2250
pubmed: 31681259
Nat Immunol. 2017 Feb;18(2):123-131
pubmed: 28092374
Nat Rev Drug Discov. 2017 May;16(5):315-337
pubmed: 28303026
Cancer Prev Res (Phila). 2017 Jul;10(7):377-388
pubmed: 28468928
Cancer Epidemiol Biomarkers Prev. 2002 Aug;11(8):739-44
pubmed: 12163327
Cancer. 2008 Apr 1;112(7):1462-70
pubmed: 18260092
Front Biosci. 2005 Sep 01;10:2150-64
pubmed: 15970484
Gastroenterology. 2007 Aug;133(2):599-607
pubmed: 17681179
J Biol Chem. 2009 Oct 2;284(40):27135-45
pubmed: 19648115
J Immunol. 2017 May 1;198(9):3507-3514
pubmed: 28341670
Gastroenterology. 1995 Jul;109(1):325-7
pubmed: 7541001
Br J Pharmacol. 2018 Jul;175(13):2554-2565
pubmed: 29667180
Front Oncol. 2018 Aug 06;8:299
pubmed: 30131940
J Biol Chem. 1999 Oct 29;274(44):31713-8
pubmed: 10531382
Cell Host Microbe. 2021 Sep 8;29(9):1342-1350.e5
pubmed: 34358433
Cancer Res. 2000 Sep 15;60(18):5151-7
pubmed: 11016642
J Clin Invest. 1998 Dec 15;102(12):2072-81
pubmed: 9854042
Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):7846-51
pubmed: 11438734
Prz Gastroenterol. 2019;14(2):89-103
pubmed: 31616522
Nat Rev Gastroenterol Hepatol. 2017 Nov;14(11):633-634
pubmed: 28930293
Technol Cancer Res Treat. 2019 Jan 1;18:1533033819831068
pubmed: 30798772
Eur J Immunol. 2014 Jul;44(7):1956-66
pubmed: 24771148
Cell. 1990 Nov 30;63(5):941-8
pubmed: 1701694
Am J Pathol. 2002 Dec;161(6):2169-78
pubmed: 12466132
Am J Cancer Res. 2017 Jan 01;7(1):41-52
pubmed: 28123846
Expert Rev Clin Pharmacol. 2017 May;10(5):549-557
pubmed: 28162021
Infect Immun. 1996 Dec;64(12):5144-50
pubmed: 8945558
Invest New Drugs. 2017 Oct;35(5):634-641
pubmed: 28527133
N Engl J Med. 2016 Dec 8;375(23):2255-2262
pubmed: 27959684
World J Gastroenterol. 2016 Sep 28;22(36):8070-7
pubmed: 27688649
J Clin Invest. 2010 May;120(5):1368-79
pubmed: 20440079
Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2380-5
pubmed: 12591946
PLoS One. 2017 Dec 19;12(12):e0189953
pubmed: 29261789
J Biol Chem. 1992 Apr 5;267(10):6479-82
pubmed: 1313005
Infect Immun. 2010 May;78(5):1824-31
pubmed: 20231404
J Nucl Med. 2002 Mar;43(3):392-9
pubmed: 11884500
Eur J Hum Genet. 2015 Jul;23(7):990-2
pubmed: 25370039
Am J Pathol. 2007 Dec;171(6):1847-58
pubmed: 17974601
J Virol. 2010 Jan;84(1):630-8
pubmed: 19846512
EMBO J. 1994 Mar 1;13(5):1065-72
pubmed: 7510634
Nat Rev Gastroenterol Hepatol. 2019 Jun;16(6):361-375
pubmed: 30886395
Am J Physiol Cell Physiol. 2014 Feb 15;306(4):C343-53
pubmed: 24259420
Nat Rev Immunol. 2016 Feb;16(2):102-11
pubmed: 26781939
PLoS One. 2013 Nov 11;8(11):e79180
pubmed: 24244444
J Immunother Cancer. 2020 Aug;8(2):
pubmed: 32819976
J Clin Invest. 1997 Sep 15;100(6):1590-5
pubmed: 9294128
Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10464-8
pubmed: 7902563
N Engl J Med. 2019 Jan 3;380(1):45-56
pubmed: 30501490
J Natl Cancer Inst. 2008 Jul 2;100(13):950-61
pubmed: 18577748
Adv Exp Med Biol. 2009;656:85-106
pubmed: 19928355
Nat Rev Immunol. 2012 Jul 25;12(8):592-605
pubmed: 22828912
Cancer Biol Ther. 2020 May 3;21(5):441-451
pubmed: 32037952
Lancet Infect Dis. 2017 Nov;17(11):1133-1161
pubmed: 28843578
Pharmacol Ther. 2019 Sep;201:103-119
pubmed: 31028837
Proc Natl Acad Sci U S A. 1980 Jun;77(6):3464-8
pubmed: 6932031
Cancer Biol Ther. 2016 Jul 2;17(7):713-8
pubmed: 27104761
Clin Cancer Res. 2016 Oct 15;22(20):5049-5057
pubmed: 27178743
Cancer Res. 2008 Jun 1;68(11):4258-68
pubmed: 18519685
Cancer Immunol Res. 2018 May;6(5):509-516
pubmed: 29615399
Carcinogenesis. 1999 Aug;20(8):1425-31
pubmed: 10426787
Hum Pathol. 2019 May;87:103-114
pubmed: 30716341
Biochem Biophys Res Commun. 1991 Sep 30;179(3):1455-63
pubmed: 1718270
Pediatr Dev Pathol. 2018 May-Jun;21(3):285-295
pubmed: 28847213
J Clin Invest. 2011 Sep;121(9):3578-88
pubmed: 21865642
J Clin Oncol. 2012 Jan 1;30(1):60-70
pubmed: 22124103
Vaccine. 2019 Nov 28;37(50):7381-7390
pubmed: 29352598
Nature. 2012 Jul 18;487(7407):330-7
pubmed: 22810696
BMC Evol Biol. 2006 Mar 20;6:26
pubmed: 16549024
Proc Natl Acad Sci U S A. 1992 Feb 1;89(3):947-51
pubmed: 1346555
Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2705-10
pubmed: 9122260
J Biol Chem. 2015 Jan 23;290(4):1952-65
pubmed: 25480791
Antibodies (Basel). 2020 Jan 08;9(1):
pubmed: 31936270
J Biomed Res. 2017 Jan 19;31(3):189-196
pubmed: 28808213
Blood. 2011 Apr 28;117(17):4542-51
pubmed: 21300981
Gut. 2002 May;50 Suppl 3:III9-14
pubmed: 11953326
Cancer Prev Res (Phila). 2012 Jun;5(6):822-33
pubmed: 22556201
J Anat. 1994 Apr;184 ( Pt 2):407-17
pubmed: 8014132
Ann Intern Med. 1999 Dec 7;131(11):805-12
pubmed: 10610624
Biochem Pharmacol. 2020 Aug;178:114040
pubmed: 32422138
Exp Mol Med. 2014 Mar 14;46:e84
pubmed: 24626170
Lab Invest. 1998 Jan;78(1):101-8
pubmed: 9461126
Toxins (Basel). 2017 Sep 15;9(9):
pubmed: 28914772
Semin Cancer Biol. 2019 Apr;55:37-52
pubmed: 29775690
Cancer Prev Res (Phila). 2018 Feb;11(2):81-92
pubmed: 29301746
CA Cancer J Clin. 2020 May;70(3):145-164
pubmed: 32133645
Blood. 2010 May 6;115(18):3718-25
pubmed: 20200354
Cancer Prev Res (Phila). 2017 Jun;10(6):345-354
pubmed: 28396341
World J Gastrointest Pharmacol Ther. 2017 Feb 6;8(1):47-59
pubmed: 28217374
Biochem Biophys Res Commun. 1997 Oct 20;239(2):463-6
pubmed: 9344852
J Biol Chem. 1991 Sep 25;266(27):17912-8
pubmed: 1680854
N Engl J Med. 2017 Dec 28;377(26):2531-2544
pubmed: 29226797
J Biol Chem. 1991 Mar 25;266(9):5934-41
pubmed: 2005130
CA Cancer J Clin. 2017 Jan;67(1):7-30
pubmed: 28055103
Biochemistry. 2006 Feb 14;45(6):1888-98
pubmed: 16460035
Clin Cancer Res. 2020 May 1;26(9):2188-2202
pubmed: 31996389
Nat Rev Immunol. 2018 Oct;18(10):635-647
pubmed: 30057419
Mol Cell Biochem. 2002 Jan;230(1-2):73-83
pubmed: 11952098
World J Gastrointest Surg. 2016 Mar 27;8(3):179-92
pubmed: 27022445
Cancer Res. 2016 Jan 15;76(2):339-46
pubmed: 26773096
Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5426-35
pubmed: 17855649

Auteurs

John C Flickinger (JC)

Department of Pharmacology & Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA 19107, USA.

Jeffrey A Rappaport (JA)

Department of Pharmacology & Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA 19107, USA.

Joshua R Barton (JR)

Department of Pharmacology & Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA 19107, USA.

Trevor R Baybutt (TR)

Department of Pharmacology & Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA 19107, USA.

Amanda M Pattison (AM)

Department of Pharmacology & Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA 19107, USA.

Adam E Snook (AE)

Department of Pharmacology & Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA 19107, USA.

Scott A Waldman (SA)

Department of Pharmacology & Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA 19107, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH